Cellectar Biosciences - 14 Year Stock Price History | CLRB
Historical daily share price chart and data for Cellectar Biosciences since 2005 adjusted for splits. The latest closing stock price for Cellectar Biosciences as of July 19, 2019 is 2.10.
- The all-time high Cellectar Biosciences stock price is 1034280.00, which is 49251328.6% above the current share price.
- The Cellectar Biosciences 52-week high stock price is 6.70, which is 219% above the current share price.
- The Cellectar Biosciences 52-week low stock price is 1.29, which is 38.6% below the current share price.
- The average Cellectar Biosciences stock price for the last 52 weeks is 2.39.
| Cellectar Biosciences Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 2.1511 | 1.5800 | 2.8500 | 1.5800 | 2.1000 | 35.48% |
| 2018 | 7.0838 | 13.7000 | 13.7000 | 1.2900 | 1.5500 | -88.69% |
| 2017 | 17.2692 | 12.8000 | 26.6000 | 11.2000 | 13.7000 | 12.30% |
| 2016 | 31.0365 | 73.2000 | 76.1500 | 10.5000 | 12.2000 | -83.40% |
| 2015 | 250.6595 | 306.0100 | 355.0000 | 68.5000 | 73.5000 | -76.21% |
| 2014 | 552.5469 | 760.0000 | 840.0000 | 198.9500 | 309.0000 | -58.24% |
| 2013 | 910.9524 | 1480.0000 | 1580.0000 | 600.0000 | 740.0000 | -50.00% |
| 2012 | 1921.5200 | 900.0000 | 4000.0000 | 860.0000 | 1480.0000 | 68.18% |
| 2011 | 4315.7937 | 12240.0000 | 15300.0000 | 740.0000 | 880.0000 | -90.41% |
| 2010 | 113632.8571 | 908820.0000 | 908820.0000 | 6120.0000 | 9180.0000 | -98.82% |
| 2009 | 215997.1429 | 143820.0000 | 777240.0000 | 104040.0000 | 777240.0000 | 440.43% |
| 2008 | 158587.8261 | 186660.0000 | 244800.0000 | 67320.0000 | 143820.0000 | -21.67% |
| 2007 | 260855.8566 | 275400.0000 | 416160.0000 | 131580.0000 | 183600.0000 | -31.82% |
| 2006 | 374575.6972 | 581400.0000 | 691560.0000 | 192780.0000 | 269280.0000 | -56.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.020B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $154.348B | 29.07 |
| Medtronic (MDT) | Ireland | $135.189B | 19.31 |
| Stryker (SYK) | United States | $77.613B | 27.70 |
| Boston Scientific (BSX) | United States | $58.755B | 28.17 |
| Baxter (BAX) | United States | $42.395B | 26.72 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $29.186B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.855B | 41.28 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.565B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.282B | 16.24 |
| Terumo (TRUMY) | Japan | $22.330B | 25.68 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $18.881B | 0.00 |
| ResMed (RMD) | United States | $17.703B | 33.82 |
| Sunny Optical Technology (SNPTF) | China | $12.345B | 0.00 |
| Canopy Growth (CGC) | Canada | $12.272B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.392B | 49.79 |
| William Demant Holdings (WILYY) | Denmark | $7.263B | 0.00 |
| Insulet (PODD) | United States | $7.231B | 526.83 |
| Hill-Rom Holdings (HRC) | United States | $7.018B | 21.28 |
| Perrigo (PRGO) | Ireland | $7.012B | 11.85 |
| Aurora Cannabis (ACB) | Canada | $6.936B | 68.40 |
| GN STORE NORD (GNNDY) | Denmark | $6.409B | 32.73 |
| Haemonetics (HAE) | United States | $6.251B | 51.03 |
| ICU Medical (ICUI) | United States | $5.188B | 30.95 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.991B | 0.00 |
| Neogen (NEOG) | United States | $3.334B | 54.21 |
| NuVasive (NUVA) | United States | $3.016B | 24.63 |
| Hutchison China MediTech (HCM) | China | $2.777B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.746B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.480B | 52.83 |
| Quidel (QDEL) | United States | $2.268B | 23.54 |
| Aphria (APHA) | $1.604B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.543B | 886.40 |
| Phibro Animal Health (PAHC) | United States | $1.216B | 18.22 |
| AtriCure (ATRC) | United States | $1.203B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.174B | 24.93 |
| NanoString Technologies (NSTG) | United States | $1.114B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $1.097B | 29.13 |
| PetIQ (PETQ) | United States | $1.015B | 24.66 |
| Quanterix (QTRX) | United States | $0.779B | 0.00 |
| Cerus (CERS) | United States | $0.761B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.750B | 21.04 |
| Omeros (OMER) | United States | $0.719B | 0.00 |
| MacroGenics (MGNX) | United States | $0.717B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.681B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.598B | 28.97 |
| OraSure Technologies (OSUR) | United States | $0.530B | 24.40 |
| Surmodics (SRDX) | United States | $0.527B | 76.59 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.499B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.492B | 15.04 |
| BioLife Solutions (BLFS) | United States | $0.330B | 103.12 |
| Utah Medical Products (UTMD) | United States | $0.321B | 22.20 |
| Vapotherm (VAPO) | United States | $0.320B | 0.00 |
| Zynex (ZYXI) | United States | $0.251B | 25.77 |
| Cytosorbents (CTSO) | United States | $0.242B | 0.00 |
| Bovie Medical (APYX) | United States | $0.214B | 0.00 |
| Chimerix (CMRX) | United States | $0.188B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.174B | 0.00 |
| United Health Products (UEEC) | United States | $0.170B | 0.00 |
| Owens & Minor (OMI) | United States | $0.166B | 3.52 |
| Fonar (FONR) | United States | $0.142B | 7.49 |
| Female Health (VERU) | United States | $0.134B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.103B | 0.00 |
| United-Guardian (UG) | United States | $0.092B | 20.16 |
| InfuSystems Holdings (INFU) | United States | $0.090B | 0.00 |
| Surface Oncology (SURF) | United States | $0.076B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.067B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.053B | 18.33 |
| MRI INTERVENTNS (MRIC) | United States | $0.052B | 0.00 |
